News + Filings Transactions
|
Riker Lauren Bullaro
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/05/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 643 | $38.91 | $25k | | 07/05/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 10k | $0.00 | $0 | | 06/14/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 586 | $37.47 | $22k | | 06/14/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 5.8k | $38.52 | $222.4k | | 06/14/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 7 | $39.01 | $273.1 | | 06/14/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 25k | $38.74 | $968.5k | | 06/14/2023 |
06/07/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 616 | $37.87 | $23.3k | | 06/06/2023 |
06/06/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 591 | $38.99 | $23k | | 06/06/2023 |
06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 5.8k | $0.00 | $0 | | 06/06/2022 |
06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 14.6k | $59.39 | $867.1k | | 06/06/2022 |
06/06/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1.2k | $61.37 | $70.6k | | 06/06/2022 |
03/10/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 9.3k | $10.81 | $100.5k | | 03/10/2022 |
03/10/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 900 | $71.95 | $64.8k | | 03/10/2022 |
03/10/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 8.4k | $71.14 | $597.6k | | 03/10/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2.5k | $64.97 | $162.4k | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.5k | $10.81 | $27k | | 01/18/2022 |
01/04/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 2k | $0.00 | $0 | | 01/04/2022 |
01/04/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 5k | $61.60 | $308k | | 01/04/2022 |
07/29/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 90 | $60.81 | $5.5k | | 07/28/2021 |
07/29/2021 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 90 | $10.81 | $972.9 | | 07/28/2021 |
07/28/2021 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.4k | $10.81 | $26.1k | | 07/28/2021 |
07/28/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2.4k | $60.85 | $146.6k | | 07/28/2021 |
06/11/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2k | $59.85 | $119.9k | | 06/09/2021 |
06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 6.5k | $60.96 | $396.2k | | 06/09/2021 |
06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 2.6k | $0.00 | $0 | | 06/09/2021 |
06/04/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1k | $61.04 | $63.9k | | 06/04/2021 |
03/17/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2k | $70.01 | $140k | | 03/15/2021 |
03/17/2021 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2k | $10.81 | $21.6k | | 03/15/2021 |
03/15/2021 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 1.5k | $10.81 | $16.4k | | 03/15/2021 |
03/15/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1.5k | $73.28 | $111.4k | | 03/15/2021 |
11/13/2020 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 3k | $63.81 | $191.4k | | 11/13/2020 |
11/13/2020 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 3k | $10.81 | $32.4k | | 11/13/2020 |
09/16/2020 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 3k | $10.81 | $32.4k | | 09/16/2020 |
09/16/2020 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 3k | $60.34 | $181k | | 09/16/2020 |
08/11/2020 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 8.2k | $60.50 | $494.9k | | 08/11/2020 |
|
|